Here's a short piece from the Wall Street Journal about management changes at Eli Lilly designed to "minimize bureaucracy." (Good luck with that.) Lilly has consolidated some groups and created a regulatory and medical unit in its research division, WSJ reports.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.